Identification of gene markers associated with prognosis for patients with prostate cancer

Prognostic biomarkers in prostate cancer identified through bioinformatic analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN11560295

Enrollment

1000

Registered

2021-12-01

Start date

2021-12-01

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prognostic markers of prostate cancer Cancer

Interventions

The Genematrix and clinical data of prostate cancer patients are extracted from the TCGA and GEO databases to compare tumor and normal tissue samples. Univariate and multivariate COX regression analys

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients with prostate cancer in the TCGA and GEO databases

Exclusion criteria

Exclusion criteria: Patients without prognostic information in the TCGA and GEO databases

Design outcomes

Primary

Measure	Time frame
Genes associated with biochemical recurrence, identified through bioinformatic analysis of data obtained from the TCGA and GEO database from 01/12/2021 to 05/12/2021	—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026